2022
DOI: 10.2478/jtim-2022-0009
|View full text |Cite
|
Sign up to set email alerts
|

Immune checkpoint inhibitor-related endocrinopathies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 45 publications
0
6
0
Order By: Relevance
“…Although the pathogenesis of IgAVN remain unclear, it may involve the disruption of both cellular and humoral immunity, and the release of various cytokines and inflammatory mediators ( 27 , 28 ). In our GO and KEGG enrichment analysis, hub genes were enriched in both the innate immune pathways (TLR signaling, NOD-like receptor signaling, and MAPK signaling) and the adaptive immune pathways (Th17 cell differentiation).…”
Section: Discussionmentioning
confidence: 99%
“…Although the pathogenesis of IgAVN remain unclear, it may involve the disruption of both cellular and humoral immunity, and the release of various cytokines and inflammatory mediators ( 27 , 28 ). In our GO and KEGG enrichment analysis, hub genes were enriched in both the innate immune pathways (TLR signaling, NOD-like receptor signaling, and MAPK signaling) and the adaptive immune pathways (Th17 cell differentiation).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, immunotherapy has become an active research field in the fields of cancer biology and oncology. [30,31] Our study had some limitations. First, the prognostic analysis of OS rates was based on public databases.…”
Section: Discussionmentioning
confidence: 94%
“…In addition, immunotherapy has become an active research field in the fields of cancer biology and oncology. [30,31]…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, autoantibodies are detectable months to years before autoimmune diabetes onset; upon that time, patients still possess a reasonable number of β cells that can manage blood glucose (Figure S1). With rapid progress in treatments of autoimmune disease, it is expected that there will be a way to drag or even stop the progress of autoimmune destruction. All the above demonstrates the pivotal role of antibody detection in both diabetes diagnosis and prediagnosis. Among diabetes autoantibodies, GADA is detectable in around 80% of autoimmune diabetic patients, which makes it indispensable in every single antibody test.…”
mentioning
confidence: 99%